The post COVID-19 symptoms affect the productivity and the quality of life among survivors. It is imperative to identify the effect of virus variants and the vaccination against post-COVID-19 symptoms. There were 242 participants from the eastern part of Indonesia diagnosed with COVID-19 during July 2021-July to 2022 were recruited online. The participants underwent data collection and semi-clinical follow-up for post-COVID-19 symptoms within 30 days after the first symptoms or from the diagnosis day using a validated clinical questionnaire and physician confirmation. Fatigue was the most reported post-COVID-19 symptom (27.7%), followed by chronic cough (21.5%) and headache (15.3%). Adjusted by confounding factors in hierarchical logistic regression, the differences in post-COVID-19 symptoms were insignificant across different variants. Regarding vaccine efficacy against three post-COVID-19 symptoms, people with two-dose vaccination significantly reported lower post-COVID-19 chronic cough (adjusted Odds Ratio 0.244 95% CI OR 0.071-0.838), but the protection against fatigue and the chronic headache was insignificant. There is an indication that vaccine efficacy may be waning along with the emerging new variants.
Jaringan kolaborasi para penulis
11 penulis ·
16 tautan kepenulisan bersama
· 9 lintas organisasi
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
Chulalongkorn University
Khairun University
University of Indonesia
VinUniversity
Hasanuddin University
Afiliasi tidak diketahui
Organisasi berbeda
Organisasi sama
Afiliasi tidak diketahui
Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.